2019 American Transplant Congress
Not for the Faint of Heart: The Impact of Post-Reperfusion Syndrome during Liver Transplantation Using Livers with Significant Macrosteatosis
*Purpose: The present study represents the largest series of donor livers with moderate macrosteatosis and provides detailed analysis of the effects of post reperfusion syndrome…2019 American Transplant Congress
Creating Geographic Catchment Areas for Solid Organ Transplant Centers
*Purpose: While measurement of transplant center performance has traditionally begun at listing, there is a significant population of potential candidates who may benefit from transplant…2019 American Transplant Congress
Toll Like Receptor 2 Mobilizes Regulatory T Cell Lymphatic Migration by Stimulating Lymphotoxin Expression
*Purpose: Regulatory T cell (Treg) afferent lymphatic migration is important for islet allograft survival. Treg express high levels of lymphotoxin (LT) and bind the LT…2019 American Transplant Congress
Organ Donation Survey among Health Care Professionals in Argentina
*Purpose: Our objective was to survey health care professionals (HCPs) responsible for the care of potential organ donors (PODs) on attitude toward organ donation, knowledge…2019 American Transplant Congress
Policy Changes in Facilitated Pancreas Allocation Support Pancreas Utilization
*Purpose: In an effort to address the decline in pancreas transplantation, facilitated pancreas allocation (FPA) was modified August 16, 2016 from an opt-in system for…2019 American Transplant Congress
A Safe Anti-A2 Titer for a Succesful A2 Incompatible Kidney Transplantation
Montefiore Medical Center, Bronx, NY
*Purpose: The new kidney allocation system implemented in December 2014 allowed for use of A2/A2B donors to B recipients. However there is no mandate by…2019 American Transplant Congress
Management of Anastomotic Biliary Strictures after Liver Transplant: Role of Covered Metal Stents
*Purpose: Biliary complications, including anastomotic biliary strictures (ABS), remain the most common cause of morbidity in liver transplant (LT) patients. Endoscopic therapy has become the…2019 American Transplant Congress
Sub-Optimal Renal Recovery and Progressive Chronic Kidney Disease after Living Kidney Donation
*Purpose: Post-operative renal recovery after nephrectomy is a substantial problem to be addressed in living kidney donors. Herein, we explored factors associated with renal recovery…2019 American Transplant Congress
Infectious Complications in Tocilizumab-Treated Kidney Transplant Recipients
Cedars Sinai Medical Center, Los Angeles, CA
*Purpose: Tocilizumab blocks IL-6 signaling, inhibiting maturation of B cells to plasma cells and antibody production. We have used tocilizumab since 2012 to treat kidney…2019 American Transplant Congress
Regulating T Cell Responses by Forced Transgenic Expression of Decay-Accelerating Factor
1Icahn School of Medicine at Mount Sinai, New York, NY, 2Cleveland Clinic, Cleveland, OH
*Purpose: Decay-accelerating factor (DAF, CD55) is a cell surface expressed, glycophosphatidylinositol-(GPI)-anchored, complement regulator. Previous studies showed that during cognate T cell/antigen presenting cell (APC) interactions…
- « Previous Page
- 1
- …
- 161
- 162
- 163
- 164
- 165
- …
- 214
- Next Page »
